Verapamil (Part A)
Sponsors
EpiEndo Pharmaceuticals, Johnny Ludvigsson
Conditions
COPDChronic Obstructive Pulmonary Disease ExacerbationType 1 Diabetes
Phase 1
Clinical Trial to Assess Effect of Verapamil on Systemic Exposure of EP395 and Effect of EP395 on Systemic Exposure of Midazolam and Digoxin
CompletedNCT06118684
Start: 2023-10-23End: 2024-01-02Updated: 2026-04-29
A Phase I/II Trial to Preserve Residual Insulin Secretion in Children With Recent Onset Type 1 Diabetes by Giving Verapamil
RecruitingNCT07199946
Start: 2025-08-06End: 2030-05-31Target: 36Updated: 2025-09-30